Skye Bioscience Inc (SKYE)

[zenvesting]

The company intends to uplist, so a reverse split is all but implied in their use of the word "recapitalization". I personally hope for a reverse split and subsequent uplisting, as I believe it is necessary for this highly qualified management team to raise capital at higher valuations, like a legit NASDAQ listed biotech should be valued....and to see continued share price advances as they progress through trials and demonstrate efficacy.

Their use of the word "recapitalization" may also imply the potential for a reverse merger with their majority shareholder, which I am also hopeful for if the terms are right....they now hold a large majority by percentage so one would think they have high enough interest to be serious about adding value to this public entity....I can't get into specifics of my wishful speculations here....but there is certainly potential for Emerald bringing significant additional value to the table.

DISCLOSURE: Holding a starter position and anxiously awaiting updates on their "recapitalization plan".